Rivaroxaban Treatment for Heparin-Induced Thrombocytopenia: A Case Report and a Review of the Current Experience
Heparin-induced thrombocytopenia is a life-threatening complication of exposure to heparin. Heparin-induced thrombocytopenia results from an autoantibody directed against platelet factor 4 in complex with heparin. Heparin-induced thrombocytopenia is traditionally treated with bivalirudin, argatroban...
Saved in:
Main Authors: | Mohamed Aon, Omar Al-Shammari |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Case Reports in Hematology |
Online Access: | http://dx.doi.org/10.1155/2020/8885256 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A “Catastrophic” Heparin-Induced Thrombocytopenia
by: D. Barcellona, et al.
Published: (2020-01-01) -
Heparin-Induced Thrombocytopenia Associated with Massive Intracardiac Thrombosis: A Case Report
by: Atheer Ahmed, et al.
Published: (2012-01-01) -
An atypical case of acute thrombocytopenia induced by rivaroxaban in a patient with NSCLC undergoing furmonertinib treatment
by: Zhao Luping, et al.
Published: (2025-02-01) -
Low Molecular Weight Heparin Induced Skin Necrosis without Platelet Fall Revealing Immunoallergic Heparin Induced Thrombocytopenia
by: Thomas Godet, et al.
Published: (2013-01-01) -
Heparin-Induced Thrombocytopenia in a Patient with Essential Thrombocythemia: A Case Based Update
by: Edva Noel, et al.
Published: (2015-01-01)